Form 4: TransMedics GC Exercises, Sells Shares

TransMedics Group's Senior VP, General Counsel, and Secretary, Anil P. Ranganath, exercised stock options and subsequently sold an equal number of shares.

Summary

• Anil P. Ranganath, Senior Vice President, General Counsel, and Secretary of TransMedics Group, Inc., engaged in a stock option exercise and sale transaction.
• On November 25, 2025, Ranganath exercised options to acquire 3,000 shares of common stock at an exercise price of $93.88 per share.
• Immediately following the exercise, Ranganath sold 3,000 shares of common stock at a weighted average price of $145.22 per share.
• The sale price ranged from $145.00 to $145.65 per share.
• Following these transactions, Ranganath directly owns 13,955 shares of common stock and 7,420 stock options.
• The options exercised were part of a grant that vested 25% on June 5, 2024, with the remainder vesting in equal monthly installments over three years thereafter.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction where an officer exercised options and sold shares for a profit. This is generally neutral, but the profit realized could be seen as a positive indicator of past stock performance. It does not indicate any fundamental change in the company's operations or outlook.

Positives

• The officer realized a profit from exercising options at $93.88 and selling shares at a weighted average of $145.22, indicating a significant gain per share of approximately $51.34.
• The transaction demonstrates liquidity for the officer and potentially reflects confidence in the company's stock performance leading up to the sale price.

Negatives

• The sale of 3,000 shares by a senior officer could be interpreted as a reduction in direct ownership, although it is a common practice for option exercises.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This Form 4 filing details an insider transaction, which is a routine disclosure for publicly traded companies. It does not provide information directly related to broader industry trends or competitive landscape, but rather reflects an individual officer's compensation and personal investment activity within TransMedics Group, Inc.

Stakeholder Impact

• Shareholders: The sale by a senior officer could be viewed neutrally as a common practice for option exercises, or slightly negatively if interpreted as a reduction in insider holdings, though the officer retains significant shares and options. The profit realized by the officer might be seen as a positive reflection of the company's stock performance.
• Employees: No direct impact.
• Customers/Suppliers/Creditors: No direct impact.

Key Dates

Recommendation

This Form 4 filing details a routine 'sell-to-cover' or 'cash-out' transaction by a senior officer, where stock options were exercised and an equal number of shares were sold. While the officer realized a significant profit, this type of transaction is common for executive compensation and does not inherently signal a change in the company's fundamental outlook or performance. The officer still retains a substantial number of shares and options. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.

Keywords

TransMedics Group, TMDX, Form 4, Insider Trading, Stock Options, Share Sale, Anil P. Ranganath, Officer Transaction, Beneficial Ownership